Skip to main content
Menu
Go to Dashboard
Help
Français
Login
2.4.10 :: 2.4.10 :: 2025/07/10 12:18
Dashboard
Services
Request access
Search
Profiles
Documents
Disciplined list
Cease trade orders
View reporting issuers list
Home
Sharp Therapeutics Corp. (000056560)
Company details
Regulatory actions
On this page
Documents
Profile details
Company identification
Reporting issuer details
Formation details
Financial year end
Size and industry classification
Securities
Associated entities
Previous issuers
Documents
Search and download documents for this profile
Profile details
Profile number
000056560
Status
Public
Full legal company name in English
Sharp Therapeutics Corp.
Full legal company name in French
Sharp Therapeutics Corp.
Effective from date
11 Dec 2024
Show previous name history
Previous name in English
EVP CAPITAL INC
Previous name in French
EVP CAPITAL INC
Effective up to date
11 Dec 2024
Previous name in English
EVP CPC INC
Previous name in French
EVP CPC INC
Effective up to date
01 Jan 1500
This company is an Investment Fund Manager
No
This company is an Underwriter
No
Head office address
2403 Sidney St., Suite 264, Pittsburgh, Pennsylvania, 15203, United States of America
Mailing address
3400 One First Canadian Place, Toronto, Ontario, M5X 1A4, Canada
Telephone number
+1 (412) 206-5303 (Main)
Fax number
Email address
info@sharptx.com
Website
www.sharptx.com
Company identification
Legal Entity Identifier (LEI)
Reporting issuer details
Reporting issuer
Yes
Over-The-Counter (OTC) issuer
No
Exchangeable Security or Credit Support issuer
Not applicable
Capital Pool Company (CPC)
No
Eligible for short form prospectus
No
Principal jurisdiction
Ontario
Reporting jurisdiction(s)
Alberta, British Columbia, Ontario
Formation details
Date of formation
04 Oct 2021
Manner of formation
Corporation
Jurisdiction where formed
Canada, Ontario
Chief Executive Officer (CEO) - full legal name
SNEDDON, Scott
Chief Financial Officer (CFO) - full legal name
JONASSON, Edward
Financial year end
Type of financial year end
Fixed year end
Financial year end
December 31
Size and industry classification
NAICS
541710 - Research and development in the physical, engineering and life sciences
Size of issuer (assets)
Under $5 million
Securities
Listed on an exchange or other market place
Yes
Select exchange(s) or other market place(s) Add at least one Stock Exchange or other Market Place
Exchange or market place
TSX Venture (TSXV) - SHRX
CUSIP
820009
ISIN
CA8200092077
Associated entities
Transfer agent or registrar
TSX Trust Company / TSX Trust Company
100 Adelaide St. West, Suite 301, Toronto, Ontario, M5H 4H1, Canada
T: +1 (416) 361-0930
F: [Not Provided]
notdefined@notdefined.com
Auditor
MNP LLP / MNP LLP
Address
1 Adelaide St. East, Toronto, Ontario, M5C 2V9, Canada
T: +1 (647) 596-1711
notdefined@notdefined.com
Previous issuers
Previous issuer(s)
No
Unsaved changes will be lost. Are you sure you wish to exit?
No
Yes
Unsaved changes will be lost. Are you sure you want to cancel?
No
Yes
???label.checkSubmitMsg???
Cancel
???label.submitOnly???
Hide page help
About SEDAR+
Contact Us
Glossary
Copyright © 2023 British Columbia Securities Commission, Alberta Securities Commission, Ontario Securities Commission, Autorité des marchés financiers. All rights reserved.
2.4.10 :: 2.4.10 :: 2025/07/10 12:18
Print